Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis

• Main Authors: Céline Phan (Author), Nathalie Beneton (Author), Juliette Delaunay (Author), Ziad Reguiai (Author), Claire Boulard (Author), Anne-Claire Fougerousse (Author), Elisa Cinotti (Author), Marco Romanelli (Author), Laure Mery-Bossard (Author), Domitille Thomas-Beaulieu (Author), Josiane Parier (Author), François Maccari (Author), Jean-Luc Perrot (Author), Mireille Ruer-Mulard (Author), Marie Bastien (Author), Edouard Begon (Author), Mahtab Samimi (Author), Caroline Jacobzone (Author), Nathalie Quiles-Tsimaratos (Author), Vincent Descamps (Author), Maud Steff (Author), Paul Bilan (Author), Annie Vermersch-Langlin (Author), Mathilde Kemula (Author), Emmanuelle Amazan (Author), Ingrid Kupfer-Bessaguet (Author), Anne-Caroline Cottencin (Author), Francesca Prignano (Author), Bulai Livideanu (Author), Jeremy Gottlieb (Author), Alain Beauchet (Author), Emmanuel Mahé (Author)
• Format: Book
• Published: Medical Journals Sweden, 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Anti-interleukin-17 agents have recently been developed for the treatment of psoriasis. This study evaluated the tolerance and effectiveness of anti-interleukin-17 agents for psoriasis in elderly patients in daily practice. A multicentre, retrospective study was performed, involving psoriatic patien...